Helena Carmo

Prof. Helena Carmo

UCIBIO-REQUIMTE, Toxicology Lab, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2012 in Archives of Toxicology
Verified
Journal Article
Closed access
Márcia CarvalhoMárcia Carvalho
Márcia Carvalho
HCHelena Carmo
Helena Carmo
Vera CostaVera Costa
Vera Costa
João Paulo CapelaJoão Paulo Capela
João Paulo Capela
HPHelena Pontes
Helena Pontes
MBMaria de Lourdes Bastos
Maria de Lourdes Bastos

1 May 2015 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
RSRenata Silva
Renata Silva
VVVânia Vilas-Boas
Vânia Vilas-Boas
HCHelena Carmo
Helena Carmo
Ricardo Jorge Dinis-OliveiraRicardo Jorge Dinis-Oliveira
Ricardo Jorge Dinis-Oliveira
Félix CarvalhoFélix Carvalho
Félix Carvalho
Fernando RemiãoFernando Remião
Fernando Remião

1 December 2006 in NeuroToxicology
Verified
Journal Article
Closed access
Ricardo Jorge Dinis-OliveiraRicardo Jorge Dinis-Oliveira
Ricardo Jorge Dinis-Oliveira
Fernando RemiãoFernando Remião
Fernando Remião
HCHelena Carmo
Helena Carmo
JDJosé Alberto Duarte
José Alberto Duarte
Amparo Sánchez NavarroAmparo Sánchez Navarro
Amparo Sánchez Navarro
Félix CarvalhoFélix Carvalho
Félix Carvalho

17 April 2009 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
João Paulo CapelaJoão Paulo Capela
João Paulo Capela
HCHelena Carmo
Helena Carmo
Fernando RemiãoFernando Remião
Fernando Remião
MBMaria Lourdes Bastos
Maria Lourdes Bastos
AMAndreas Meisel
Andreas Meisel
Félix CarvalhoFélix Carvalho
Félix Carvalho

13 April 2022 in Toxins
Verified
Journal Article
Open access
PDF file
RBRita Roque Bravo
Rita Roque Bravo
AFAna Carolina Faria
Ana Carolina Faria
ABAndreia Machado Brito-da-Costa
Andreia Machado Brito-da-Costa
HCHelena Carmo
Helena Carmo
Premysl MladenkaPremysl Mladenka
Premysl Mladenka
OROn Behalf Of The Oemonom Researchers
On Behalf Of The Oemonom Researchers
Cocaine is one of the most consumed stimulants throughout the world, as official sources report. It is a naturally occurring sympathomimetic tropane alkaloid derived from the leaves of Erythroxylon coca, which has been used by South American locals for millennia. Cocaine can usually be found in two forms, cocaine hydrochloride, a white powder, or ‘crack’ cocaine, the free base. While the first is commonly administered by insufflation (‘snorting’) or intravenously, the second is adapted for inhalation (smoking). Cocaine can exert local anaesthetic action by inhibiting voltage-gated sodium channels, thus halting electrical impulse propagation; cocaine also impacts neurotransmission by hindering monoamine reuptake, particularly dopamine, from the synaptic cleft. The excess of available dopamine for postsynaptic activation mediates the pleasurable effects reported by users and contributes to the addictive potential and toxic effects of the drug. Cocaine is metabolised (mostly hepatically) into two main metabolites, ecgonine methyl ester and benzoylecgonine. Other metabolites include, for example, norcocaine and cocaethylene, both displaying pharmacological action, and the last one constituting a biomarker for co-consumption of cocaine with alcohol. This review provides a brief overview of cocaine’s prevalence and patterns of use, its physical-chemical properties and methods for analysis, pharmacokinetics, pharmacodynamics, and multi-level toxicity.

1 November 2014 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
SFSónia Fraga
Sónia Fraga
ABAna Brandão
Ana Brandão
MSMaria Elisa Soares
Maria Elisa Soares
TMTiago Morais
Tiago Morais
JDJosé Alberto Duarte
José Alberto Duarte
HCHelena Carmo
Helena Carmo